Pegintron and Dry skin - a phase IV clinical study of FDA data
Summary:
Dry skin is found among people who take Pegintron, especially for people who are female, 50-59 old, have been taking the drug for 1 - 6 months.
The phase IV clinical study analyzes which people take Pegintron and have Dry skin. It is created by eHealthMe based on reports of 10,284 people who have side effects when taking Pegintron from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
10,284 people reported to have side effects when taking Pegintron.
Among them, 153 people (1.49%) have Dry skin.
What is Pegintron?
Pegintron has active ingredients of peginterferon alfa-2b. It is often used in hepatitis c. eHealthMe is studying from 10,315 Pegintron users for its effectiveness, alternative drugs and more.
What is Dry skin?
Dry skin is found to be associated with 2,970 drugs and 2,288 conditions by eHealthMe.
Number of Pegintron and Dry skin reports submitted per year:
Time on Pegintron when people have Dry skin *:
Gender of people who have Dry skin when taking Pegintron*:
Age of people who have Dry skin when taking Pegintron *:
Common drugs people take besides Pegintron *:
Common side effects people have besides Dry skin *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Pegintron and have Dry skin?
Check whether Dry skin is associated with a drug or a conditionHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related studies
How severe was Dry skin and when was it recovered:
Expand to all the drugs that have ingredients of peginterferon alfa-2b:
Alternative drugs to, pros and cons of Pegintron:
- Pegintron (10,315 reports)
Common Pegintron side effects:
- Fatigue (feeling of tiredness): 1,231 reports
- Rashes (redness): 1,150 reports
- Thrombocytopenia (decrease of platelets in blood): 1,145 reports
- Fever: 1,000 reports
- Appetite - decreased (decreased appetite occurs when you have a reduced desire to eat): 816 reports
- Headache (pain in head): 769 reports
Browse all side effects of Pegintron:
a b c d e f g h i j k l m n o p q r s t u v w x y zDry skin treatments and more:
- Dry skin (110,871 reports)
COVID vaccines that are related to Dry skin:
- Dry skin in Moderna COVID Vaccine
- Dry skin in Pfizer BioNTech Covid Vaccine
- Dry skin in Johnson and Johnson Covid Vaccine
Common drugs associated with Dry skin:
- Adapalene: 42,690 reports
- Green tea: 19,269 reports
- Dupixent: 4,984 reports
- Accutane: 3,405 reports
- Aspirin: 2,781 reports
- Humira: 2,751 reports
- Prednisone: 2,537 reports
- Vitamin d: 2,061 reports
- Enbrel: 1,918 reports
- Synthroid: 1,893 reports
All the drugs that are associated with Dry skin:
- Dry skin (2,970 drugs)
Common conditions associated with Dry skin:
- Acne: 27,769 reports
- Psoriasis: 2,749 reports
- Rheumatoid arthritis: 2,646 reports
- High blood pressure: 2,167 reports
- Multiple myeloma: 1,916 reports
- Hepatitis c: 1,808 reports
- Multiple sclerosis: 1,501 reports
All the conditions that are associated with Dry skin:
- Dry skin (2,288 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on peginterferon alfa-2b (the active ingredients of Pegintron) and Pegintron (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Rivaroxaban and Ischaemic Cardiomyopathy - a minute ago
- Evista and Seizures - a minute ago
- Pradaxa and Pleural Effusion - a minute ago
- Sick Sinus Syndrome and pfizer biontech covid vaccine - a minute ago
- Montelukast Sodium and Acetaminophen drug interaction - 2 minutes ago
- Sulindac and Amylase Increased - 2 minutes ago
- Ventolin Hfa and Symmetrel drug interaction - 3 minutes ago
- Tetany in Adderall, how severe and when it was recovered? - 3 minutes ago
- Vitamin B6 and Nightmares - 4 minutes ago
- Seroquel and Stent - 4 minutes ago